​

Third Harmonic Bio Ownership | Who Owns Third Harmonic Bio?

OverviewForecastFinancialsChart

Third Harmonic Bio Ownership Summary

Third Harmonic Bio is owned by 86.15% institutional investors, 9.11% insiders, and 4.74% retail investors. Atlas venture life science advisors is the largest institutional shareholder, holding 23.16% of THRD shares. T. Rowe Price Small-Cap Value is the top mutual fund, with 1.94% of its assets in Third Harmonic Bio shares.

THRD Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockThird Harmonic Bio86.15%9.11%4.74%
SectorHealthcare Stocks 486.50%11.08%-397.59%
IndustryBiotech Stocks 304.14%11.08%-215.23%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Atlas venture life science advisors10.40M23.16%$56.48M
Orbimed advisors5.78M12.87%$31.38M
Bml capital management3.82M8.51%$20.77M
Nantahala capital management2.94M6.54%$15.96M
Fmr2.54M6.14%$26.10M
Boxer capital2.00M4.93%$26.00M
Tcg crossover management1.92M4.26%$10.40M
Blackrock funding, inc. /de1.73M3.84%$9.38M
Blackrock1.43M3.55%$18.56M
Vanguard group1.03M2.49%$10.60M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Bml capital management3.82M15.71%$20.77M
Atlas venture life science advisors10.40M8.53%$56.48M
Boxer capital2.00M1.37%$26.00M
Tcg crossover management1.92M1.19%$10.40M
Takeda pharmaceutical36.84K1.02%$200.01K
Orbimed advisors5.78M0.79%$31.38M
Nantahala capital management2.94M0.63%$15.96M
Yakira capital management293.63K0.54%$1.59M
Adar1 capital management622.87K0.52%$3.38M
Alpine global management334.48K0.41%$1.82M

Top Buyers

HolderShares% AssetsChange
Fmr2.54M0.00%2.23M
Millennium management640.08K0.00%558.62K
Adar1 capital management622.87K0.52%522.87K
Dld asset management, lp503.84K0.15%503.84K
Omers administration426.90K0.02%426.90K

Top Sellers

HolderShares% AssetsChange
General atlantic---3.37M
Ecor1 capital---3.18M
T. rowe price investment management---2.93M
Bvf inc/il---2.37M
Deerfield management company, l.p. (series c)---1.02M

New Positions

HolderShares% AssetsChangeValue
Dld asset management, lp503.84K0.15%503.84K$2.74M
Omers administration426.90K0.02%426.90K$2.32M
Alpine global management334.48K0.41%334.48K$1.82M
Yakira capital management293.63K0.54%293.63K$1.59M
Gabelli & co investment advisers251.68K0.21%251.68K$1.37M

Sold Out

HolderChange
Capital performance advisors llp-25.00
Ronald blue trust-58.00
Corecap advisors-123.00
Creative planning-130.00
Simplex trading-153.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20251079.18%38,695,31936.78%862.17%681.49%1730.77%
Mar 31, 2025992.06%38,690,688-13.85%860.73%678.06%13-31.58%
Dec 31, 20249410.59%44,487,8861.04%1070.95%5918.00%195.56%
Sep 30, 20248513.33%44,027,8929.42%1061.08%508.70%1820.00%
Jun 30, 2024758.70%40,236,4216.25%991.12%4635.29%15-16.67%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
T. Rowe Price Small-Cap Value872.50K1.94%-634.00
Vanguard Total Stock Mkt Idx Inv719.66K1.59%-
Fidelity Select Health Care680.00K1.52%-
iShares Russell 2000 ETF603.45K1.34%-
Fidelity Small Cap Growth548.60K1.22%-
T. Rowe Price US Small-Cap Core Equity544.31K1.21%-20.31K
Vanguard US Total Market Shares ETF517.12K1.15%-
T. Rowe Price U.S. SC Value Eq Tr-Z483.81K1.07%40.76K
T. Rowe Price U.S. SC Value Eq Tr-D483.81K1.07%40.76K
Fidelity Advisor Health Care I400.00K0.89%-

Recent Insider Transactions

DateNameRoleActivityValue
Nov 08, 2024Conner Edward R. Chief Medical OfficerSell$31.75K
Oct 29, 2024BVF PARTNERS L P/IL See Explanation of ResponsesSell$5.68M
Oct 29, 2024BVF PARTNERS L P/IL See Explanation of ResponsesSell$7.70M
Oct 29, 2024BVF PARTNERS L P/IL See Explanation of ResponsesSell$924.02K
Oct 28, 2024Conner Edward R. Chief Medical OfficerSell$40.09K

Insider Transactions Trends

DateBuySell
2025 Q1--
2024 Q4-5
2024 Q3-3
2024 Q2-7
2024 Q1--

THRD Ownership FAQ

Who Owns Third Harmonic Bio?

Third Harmonic Bio shareholders are primarily institutional investors at 86.15%, followed by 9.11% insiders and 4.74% retail investors. The average institutional ownership in Third Harmonic Bio's industry, Biotech Stocks , is 304.14%, which Third Harmonic Bio falls below.

Who owns the most shares of Third Harmonic Bio?

Third Harmonic Bio’s largest shareholders are Atlas venture life science advisors (10.4M shares, 23.16%), Orbimed advisors (5.78M shares, 12.87%), and Bml capital management (3.82M shares, 8.51%). Together, they hold 44.54% of Third Harmonic Bio’s total shares outstanding.

Does Blackrock own Third Harmonic Bio?

Yes, BlackRock owns 3.55% of Third Harmonic Bio, totaling 1.43M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 18.56M$. In the last quarter, BlackRock increased its holdings by 65.78K shares, a 4.83% change.

Who is Third Harmonic Bio’s biggest shareholder by percentage of total assets invested?

Bml capital management is Third Harmonic Bio’s biggest shareholder by percentage of total assets invested, with 15.71% of its assets in 3.82M Third Harmonic Bio shares, valued at 20.77M$.

Who is the top mutual fund holder of Third Harmonic Bio shares?

T. Rowe Price Small-Cap Value is the top mutual fund holder of Third Harmonic Bio shares, with 1.94% of its total shares outstanding invested in 872.5K Third Harmonic Bio shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools